Stem Cell Survival Compounds for E-Cadherin Stabilization

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing chemically-defined media for culturing embryonic stem cells (ESCs) are unsatisfactory due to suboptimal cell performance and extensive cell death during passaging, with no known signaling pathways acting as survival factors during this process.

Innovation Solution

Compounds with specific structural formulas, including substituted or unsubstituted cycloalkyl, heterocycloalkyl, aryl, or heteroaryl rings, are used to stabilize isolated cells and enhance survival by stabilizing E-cadherin and activating protein kinase C (PKC), thereby maintaining cell viability during environmental changes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If chemically-defined media are used for culturing embryonic stem cells, then cell culture conditions are improved and defined, but cell survival rate deteriorates during passaging

Engineering Contradiction:

Improvecell culture condition definitionVSAvoidcell survival rate

Core Design Contradiction:

Ease of manufactureVSReliability

Solution Approach 1:

The patent introduces a small molecule compound as an intermediary agent that mediates between the chemically-defined culture conditions and the cell survival mechanism. This compound activates protein kinase C signaling pathways, which in turn stabilizes E-cadherin and prevents cell death during passaging, thus bridging the gap between defined culture conditions and improved cell survival.

Inventive Principle:

Principle #24Intermediary (Mediator)

2Ease of operation

If cells are passaged by trypsin to single cells, then cell separation is achieved, but cell death increases extensively

Engineering Contradiction:

Improvecell separationVSAvoidcell death rate

Core Design Contradiction:

Ease of operationVSReliability

Solution Approach 1:

The patent applies preliminary anti-action by pre-treating cells with the small molecule compound before trypsin passaging. This pre-treatment activates protective signaling pathways that prevent the harmful effects of trypsin exposure, thereby reducing cell death while maintaining the ease of cell separation operation.

Inventive Principle:

Principle #9Preliminary anti-action

3Productivity

If signaling pathways are activated for self-renewal, then cell proliferation is enhanced, but survival factor function remains elusive

Engineering Contradiction:

Improvecell self-renewalVSAvoidmolecular mechanism understanding

Core Design Contradiction:

ProductivityVSLoss of information

Solution Approach 1:

The patent changes the molecular parameter by introducing a small molecule compound that specifically targets and activates protein kinase C signaling. This activation leads to stabilization of E-cadherin protein levels and prevents cell death, thereby elucidating the molecular mechanism linking signaling pathway activation to cell survival during passaging.

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compounds significantly improve cell survival by at least 2-fold compared to untreated cells, maintaining cell phenotype and reducing cell death during isolation and environmental changes.

Implementation Method 1

enhance survival by stabilizing E-cadherin

Methodology Applied

Scientific EffectE-cadherin stabilization:

Implementation Method 2

activating protein kinase C (PKC), thereby maintaining cell viability during environmental changes

Methodology Applied

Scientific EffectProtein kinase C activation:

Data Source

PatentUS12410397B2Methods of enhancing cell survival of stem cells

Publication Date: 2025.09.09 THE SCRIPPS RES INST

AI summary

The present invention relates compounds for stabilizing cells and methods of their use.